Next Generation Personalized Neuroblastoma Therapy

NCT02780128 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
66
Enrollment
OTHER
Sponsor class

Stopped The goals of Part 1 (molecular screening) were met, but lack of therapies to match molecular aberrations made Part 2 (treatment) no longer feasible.

Conditions

Interventions

Sponsor

Yael P Mosse

Collaborators